Lyell Immunopharma, Inc. (LYEL) Total liabilities 2020–2025
Lyell Immunopharma, Inc. (LYEL) total liabilities at each fiscal year-end, per SEC filings.
$91.8MFY2025 · since FY2020: $189.8M → $91.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $91.8M | -15.0% |
| FY2024 | $108.0M | +13.6% |
| FY2023 | $95.1M | -8.9% |
| FY2022 | $104.3M | -47.2% |
| FY2021 | $197.6M | +4.1% |
| FY2020 | $189.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice